Evidence map›Paper›PMID 32615972›Full record

ArticleBMC bioinformatics2020

USMPep: universal sequence models for major histocompatibility complex binding affinity prediction.

Johanna Vielhaben, Markus Wenzel, Wojciech Samek, Nils Strodthoff

Abstract read
In one paragraph

Article in BMC bioinformatics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Representation learning applications in biological sequence analysis.Computational and structural biotechnology journal · 2021
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Johanna VielhabenFraunhofer Heinrich Hertz Institute, Einsteinufer 37, Berlin, 10587, Germany.
Markus WenzelFraunhofer Heinrich Hertz Institute, Einsteinufer 37, Berlin, 10587, Germany.
Wojciech SamekFraunhofer Heinrich Hertz Institute, Einsteinufer 37, Berlin, 10587, Germany.
Nils StrodthoffFraunhofer Heinrich Hertz Institute, Einsteinufer 37, Berlin, 10587, Germany. nils.strodthoff@hhi.fraunhofer.de.ORCID http://orcid.org/0000-0003-4447-0162

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImmunotherapy is a promising route towards personalized cancer treatment. A key algorithmic challenge in this process is to decide if a given peptide (neoepitope) binds with the major histocompatibility complex (MHC). This is an active area of research and there are many MHC binding prediction algorithms that can predict the MHC binding affinity for a given peptide to a high degree of accuracy. However, most of the state-of-the-art approaches make use of complicated training and model selection procedures, are restricted to peptides of a certain length and/or rely on heuristics.

resultsWe put forward USMPep, a simple recurrent neural network that reaches state-of-the-art approaches on MHC class I binding prediction with a single, generic architecture and even a single set of hyperparameters both on IEDB benchmark datasets and on the very recent HPV dataset. Moreover, the algorithm is competitive for a single model trained from scratch, while ensembling multiple regressors and language model pretraining can still slightly improve the performance. The direct application of the approach to MHC class II binding prediction shows a solid performance despite of limited training data.

conclusionsWe demonstrate that competitive performance in MHC binding affinity prediction can be reached with a standard architecture and training procedure without relying on any heuristics.

Indexed as

AlgorithmsModels, GeneticAllelesArea Under CurveBase SequenceDatabases, GeneticHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHumansPeptidesProtein BindingROC CurveHistocompatibility Antigens Class IHistocompatibility Antigens Class IIPeptidesBinding affinity predictionLanguage modelingMajor histocompatibility complexPeptide dataRecurrent neural networks

Identifiers

PMID32615972
PMCPMC7330990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.